Timing of testing and treatment for asymptomatic diseases
From MaRDI portal
Publication:985247
Recommendations
Cites work
- scientific article; zbMATH DE number 4068584 (Why is no real title available?)
- scientific article; zbMATH DE number 4068587 (Why is no real title available?)
- scientific article; zbMATH DE number 1213313 (Why is no real title available?)
- scientific article; zbMATH DE number 700091 (Why is no real title available?)
- A Two-State Partially Observable Markov Decision Process with Uniformly Distributed Observations
- Early detection of disease and scheduling of screening examinations
- Estimating distribution of the age of onset of detectable asymptomatic cancer
- Improved inspection schemes for deteriorating equipment
- Inspection policies and processes for deteriorating systems subject to catastrophic failure
- Mass Screening Models for Contagious Diseases with No Latent Period
- On Optimal Screening Ages
- Optimal Inspection and Repair of a Production Process Subject to Deterioration
- Optimal Scheduling of Fallible Inspections
- Optimal Scheduling of Inspections: A Delayed Markov Model with False Positives and Negatives
- Optimal Stopping in a Partially Observable Markov Process with Costly Information
- Optimal scheduling of examinations for the early detection of disease
- The Optimal Control of Partially Observable Markov Processes over a Finite Horizon
- Timing medical examinations via intensity functions
Cited in
(6)- Optimal \(M\)-switch surveillance policies for liver cancer in a hepatitis C-infected population
- An analytic framework to develop policies for testing, prevention, and treatment of two-stage contagious diseases
- Optimal timing to initiate medical treatment for a disease evolving as a semi-Markov process
- Cost-effective control of chronic viral diseases: finding the optimal level of screening and contact tracing
- A Markov decision process in medical treatment of Hepatitis C
- Bias in Markov models of disease
This page was built for publication: Timing of testing and treatment for asymptomatic diseases
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q985247)